Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Papulosquamous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04630652
What this trial is testing

Risankizumab Long-term Remission Study

Who this might be right for
Psoriasis
Jaehwan Kim 24
Post-approval studies (Phase 4)Study completedNCT00581555
What this trial is testing

Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy

Who this might be right for
Psoriasis
Pfizer 120
Not applicableLooking for participantsNCT06630715
What this trial is testing

Efficacy Of Upadacitinib In Psoriatic Arthritis And Comparison To Rheumatoid Arthritis.

Who this might be right for
Rheumatoid Arthritis (RAPsoriatic Arthritis (PsA
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 178
Not applicableUnknownNCT04904315
What this trial is testing

Subjects Through the Application of the Mindera Kit Part 2

Who this might be right for
Psoriasis
Mindera Health 100
Early research (Phase 1)Ended earlyNCT03971825
What this trial is testing

A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis

Who this might be right for
Healthy VolunteersPsoriasis
Celgene 131
Not applicableStudy completedNCT00893126
What this trial is testing

Premature Coronary Artery Disease (CAD) in Severe Psoriasis

Who this might be right for
PsoriasisCoronary Artery Disease
University of Michigan 46
Testing effectiveness (Phase 2)Study completedNCT02969525
What this trial is testing

Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis

Who this might be right for
Psoriatic Arthritis
UCB Biopharma S.P.R.L. 206
Post-approval studies (Phase 4)Study completedNCT04271540
What this trial is testing

MIcrovascular dysfuNction In Moderate-severe Psoriasis

Who this might be right for
PsoriasisCardiovascular Disease
Marcelo F. Di Carli, MD, FACC 36
Not applicableEnded earlyNCT06715254
What this trial is testing

A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil

Who this might be right for
Tuberculosis
Novartis Pharmaceuticals 152
Post-approval studies (Phase 4)Looking for participantsNCT07487831
What this trial is testing

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

Who this might be right for
Atopic Dermatitis (Eczema)Psoriasis
University of California, San Francisco 50
Post-approval studies (Phase 4)Study completedNCT01079988
What this trial is testing

Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence

Who this might be right for
Psoriasis
Merck KGaA, Darmstadt, Germany 41
Testing effectiveness (Phase 2)Looking for participantsNCT07321873
What this trial is testing

Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 240
Not applicableStudy completedNCT05086042
What this trial is testing

Carpal Tunnel Syndrome in Patients With Psoriatic Arthritis; Ultrasonography and Magnetic Resonance Imaging Findings

Who this might be right for
Carpal Tunnel SyndromePsoriatic Arthritis
Selcuk University 67
Not applicableLooking for participantsNCT04864886
What this trial is testing

Metabolic Profiling of Immune Responses in Immune-mediated Diseases

Who this might be right for
Primary ImmunodeficiencyPsoriasisAtopic Dermatitis+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableWithdrawnNCT03625089
What this trial is testing

Impact of Nurse-led Programme With Carotid Ultrasound on Addressing Cardiovascular Risk in Patients With Arthritis

Who this might be right for
Arthritis, RheumatoidArthritis, Psoriatic
Chinese University of Hong Kong
Testing effectiveness (Phase 2)UnknownNCT00824980
What this trial is testing

Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis

Who this might be right for
Psoriasis
Immune Technologies & Medicine GmbH 24
Not applicableUnknownNCT05283096
What this trial is testing

Survey About Diet in Chronic Inflammatory Rheumatic Diseases

Who this might be right for
Rheumatic DiseaseRheumatic DisorderInflammatory Rheumatism+6 more
Poitiers University Hospital 203
Not applicableUnknownNCT05997173
What this trial is testing

The Regulatory Role of Immune Response in Oral Lichen Planus

Who this might be right for
Oral Lichen Planus
Peking University Third Hospital 90
Testing effectiveness (Phase 2)Study completedNCT04300296
What this trial is testing

PoC Study to Evaluate the Efficacy and Safety of Secukinumab 300 mg in Patients With Lichen Planus

Who this might be right for
Lichen Planus: Cutaneous Lichen Planus, Mucosal Lichen Planus and Lichen Planopilaris
Novartis Pharmaceuticals 111
Early research (Phase 1)UnknownNCT03424629
What this trial is testing

Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis

Who this might be right for
Moderate and Severe Plaque Psoriasis
Tianjin Ever Union Biotechnology Co., Ltd. 57
Next Page